Healthcare & Life Sciences

Questcor Pharmaceuticals (QCOR)

series-c-plus

Stage

About

Questcor Pharmaceuticals was a specialty pharmaceutical company focused on developing treatments for patients with serious, difficult-to-treat autoimmune and inflammatory disorders; it completed an IPO on NASDAQ under the ticker QCOR.

Explore Questcor Pharmaceuticals (QCOR)'s full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.